What Types of Cancer Can be Treated with Immunotherapy?

Immuno Therapy Cancer treatment helps your immune system to beat cancer. It is different than the traditional way, chemotherapy, that uses drugs to kill cancer and healthy cells. Each type of cancer is unique, and immune therapy cancer treatment doesn’t work for all types of cancers or all people with cancer. However, doctors are testing continuously about immunotherapy treatment.

Some types of Immunotherapy have become a standard part of the treatment for certain types of cancer. Doctors may use it before other treatment types, with chemotherapy, or if any treatment related to cancer fails.

Immuno therapy cancer treatment can treat more than twenty kinds of cancers.

Bladder Cancer

FDA has approved six options for bladder cancer. These are

Targeted antibodies help disrupts cancer cells and alerts the immune system to target and kill them.

Cancer vaccines help your body to kill or stop cancer cells or keep them from coming back.

Immune system modulators boost your overall immune response.

FDA has approved the first immunotherapy Bacillus Calmette -Guerin cancer vaccine for bladder cancer in 1990.

Brain Cancer

According to research, there are two approved antibodies for brain and nervous system cancer treatment. Several other trials are going on to find out if Immunotherapy will work where other treatments have failed. Immunotherapy is showing significant promise in brain cancer treatment.

Breast Cancer

Earlier, doctors weren’t convinced about Immunotherapy and considered it a low option. But as per newer studies, that certain women may benefit from Immunotherapy. However, women who make too much of a protein receptor called HER2 are best for this therapy. New studies in the treatment of breast cancer show encouraging potential for long-term success.

Cervical Cancer

Cervical cancer requires three cancer vaccines to treat it. The FDA has also approved one checkpoint inhibitor and one monoclonal antibody, targeted therapy for cervical cancer. Many immunotherapy approaches are in clinical trials.

Childhood Cancer

There are many approved immunotherapy options for childhood cancer. It mainly treats leukemia, lymphoma, and brain cancer in childhood. The therapy includes targeted antibodies, checkpoint inhibitors, CAR T-cell therapy to help your immune system find and destroy cancer cells. Immunotherapy offers a potential way to treat childhood cancer without damaging conventional treatments’ long-term side effects.

Colorectal Cancer

Many targeted therapies and checkpoint inhibitors are useful for colorectal cancer. It works best for patients with specific genetic traits. However, the FDA has approved several Immunotherapies for colorectal cancer for which patients urgently need a new treatment option.

Esophageal Cancer

Although the FDA has approved two targeted therapies and one inhibitor for esophageal cancer, researchers are looking for ways to use Immunotherapy against esophageal cancer. Immunotherapy for esophageal cancer reduces recurrence and in novel combination for advanced-stage cancer.

Head and neck cancer

Immunotherapy offers exciting new treatment options for patients with mouth, throat, voice box, sinuses, nose, and salivary glands. It may also help to avoid the intense side effects of other types of treatment.

Kidney cancer

Researchers are paying a lot of attention to this cancer. Earlier, the options used for kidney cancer were targeted therapies and cytokines, which are proteins made by white blood cells that help the immune system kill cancer cells. Immunotherapy, also called renal cell cancer, has changed the treatment process and overall survival with metastatic kidney cancer.


FDA has approved several immunotherapies for leukemia, and the ongoing trials show even more significant potential for new treatments.

Liver Cancer

Although the FDA has approved hepatitis B as a preventive cancer vaccine, immunotherapy treatments can enhance the immune system response to liver cancer.

Lung cancer

Immunotherapy has shown promising results and treatment options for advanced lung cancer alone or in combination with traditional chemotherapy.


There are several FDA-approved immunotherapies for the treatment of children and adults with Hodgkin and non-Hodgkin lymphoma.


Immunotherapy has changed the way melanoma treatment is done in particular. The checkpoint inhibitors are responsible for increasing survival rates for patients with metastatic melanoma.

Ovarian cancer

Researches have shown that Immunotherapy for ovarian cancer has a good effect; although, more treatment options for patients and oncologists are urgently needed.

Pancreatic cancer

Pancreatic cancer has a few treatment options, so Immunotherapy is vital to provide patients with new hope.